MUTUAL RELEASE AND SETTLEMENT AGREEMENTMutual Release and Settlement Agreement • January 23rd, 2024 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
Contract Type FiledJanuary 23rd, 2024 Company Industry JurisdictionThis agreement is between Vitro Biopharma, Inc. (“Vitro”) and Nathan Haas (“Haas”) and shall be effective on the day on which it is signed by Haas (the “Effective Date”).
CONSULTING AGREEMENTConsulting Agreement • January 23rd, 2024 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances) • Colorado
Contract Type FiledJanuary 23rd, 2024 Company Industry JurisdictionThis Consulting Agreement (this “Agreement”) is entered into as of this 18th day of January, 2024 (the “Effective Date”), by and between (1) Nathan Haas (the “Consultant”), and (2) Vitro Biopharma, Inc., a Nevada corporation (the “Company”) and having its principal place of business at 3200 Cherry Creek Drive South, Suite 410, Denver, Colorado 80209. The Company and Consultant are collectively referred to herein as the “Parties”.